✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Zim Laboratories Ltd.

ZIMLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹332 Cr.
P/E
35.38

Zim Laboratories Ltd.

  • Zim Laboratories
  • Gennex Lab
  • Brooks Laboratories
  • TJI Pharma - Small Cap

FAQs on Zim Laboratories Ltd. Shareprice

Zim Laboratories has given lower returns compared to its competitors.
Zim Laboratories has grown at ~-6.35% over the last 3yrs while peers have grown at a median rate of 17.6%

Zim Laboratories is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Zim Laboratories is 35.69, while 3 year average PE is 29.75.
Also latest EV/EBITDA of Zim Laboratories is 11.13 while 3yr average is 11.38.

View FAQ's On Business

Growth Table

  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Balance Sheet

  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Cash Flow

  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Quarterly Results

  • Zim Laboratories Ltd.
  • Gennex Lab
  • Brooks Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Zim Laboratories Ltd. Financials

Balance sheet of Zim Laboratories is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Zim Laboratories is increasing.
Latest net debt of Zim Laboratories is ₹107 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹85.4 Crs.

No, profit is decreasing.
The profit of Zim Laboratories is ₹9.39 Crs for TTM, ₹12.17 Crs for Mar 2025 and ₹17.25 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zim Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech